← Back to headlines
Novo Nordisk Prepares U.S. Launch of Ozempic Pill
Novo Nordisk is reportedly readying the U.S. launch of its Ozempic pill, expanding the availability of the popular diabetes and weight-loss medication in an oral format.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
